Drug Type Synthetic peptide |
Synonyms Nafarelin acetate (USAN), Nafarelin Acetate Hydrate, Nafarelin acetate hydrate (JAN) + [8] |
Target |
Mechanism GnRHR agonists(Gonadotropin-releasing hormone receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date US (13 Feb 1990), |
RegulationOrphan Drug (US) |
Molecular FormulaC66H83N17O13.C2H4O2.H2O |
InChIKeyFSBTYDWUUWLHBD-UDXTWCDOSA-N |
CAS Registry86220-42-0 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D00990 | Nafarelin Acetate |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Uterine Fibroids | JP | 12 Mar 1999 | |
Endometriosis | JP | 20 Jan 1995 | |
Puberty, Precocious | US | 13 Feb 1990 |